These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10974585)

  • 1. In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene.
    Kak V; You I; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Diagn Microbiol Infect Dis; 2000 Aug; 37(4):297-9. PubMed ID: 10974585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci.
    Kariyama R; Kumon H; Chow L; Zervos MJ; Takata T; Tabata M; Chow JW
    J Antimicrob Chemother; 1998 Dec; 42(6):836-8. PubMed ID: 10052913
    [No Abstract]   [Full Text] [Related]  

  • 3. In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.
    You I; Kariyama R; Zervos MJ; Kumon H; Chow JW
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):37-41. PubMed ID: 10744365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility and molecular analysis of gentamicin-resistant enterococci.
    Chow JW; Donabedian SM; Clewell DB; Sahm DF; Zervos MJ
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):141-6. PubMed ID: 9884829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococci.
    Messick CR; Woodward J; Pendland SL
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):95-9. PubMed ID: 9823531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
    Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.
    Zarrilli R; Tripodi MF; Di Popolo A; Fortunato R; Bagattini M; Crispino M; Florio A; Triassi M; Utili R
    J Antimicrob Chemother; 2005 Nov; 56(5):827-35. PubMed ID: 16186168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic diversity of enterococci harboring the high-level gentamicin resistance gene aac(6')-Ie-aph(2'')-Ia or aph(2'')-Ie in a Japanese hospital.
    Watanabe S; Kobayashi N; Quiñones D; Nagashima S; Uehara N; Watanabe N
    Microb Drug Resist; 2009 Sep; 15(3):185-94. PubMed ID: 19728776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin.
    Landman D; Mobarakai NK; Quale JM
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1904-8. PubMed ID: 8239604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations.
    Hayden MK; Koenig GI; Trenholme GM
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1225-9. PubMed ID: 8092818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inconsistent bactericidal activity of triple-combination therapy with vancomycin, ampicillin, and gentamicin against vancomycin-resistant, highly ampicillin-resistant Enterococcus faecium.
    Fraimow HS; Venuti E
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1563-6. PubMed ID: 1510455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing prevalence of high-level gentamicin resistance among Enterococci isolated in Greece.
    Tsakris A; Pournaras S; Maniatis AN; Douboyas J; Antoniadis A
    Chemotherapy; 2001; 47(2):86-9. PubMed ID: 11173808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
    Kak V; Donabedian SM; Zervos MJ; Kariyama R; Kumon H; Chow JW
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2545-6. PubMed ID: 10952613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic diversity and epidemiology of high-level gentamicin resistant Enterococcus in a Chinese hospital.
    Qu TT; Chen YG; Yu YS; Wei ZQ; Zhou ZH; Li LJ
    J Infect; 2006 Feb; 52(2):124-30. PubMed ID: 15904965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of glycopeptides, aminoglycosides and macrolide resistance among Enterococcus faecalis and Enterococcus faecium isolates from hospitals in Tehran.
    Emaneini M; Aligholi M; Aminshahi M
    Pol J Microbiol; 2008; 57(2):173-8. PubMed ID: 18646406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular screening of virulence genes in high-level gentamicin-resistant Enterococcus faecalis and Enterococcus faecium isolated from clinical specimens in Northwest Iran.
    Hasani A; Sharifi Y; Ghotaslou R; Naghili B; Hasani A; Aghazadeh M; Milani M; Bazmani A
    Indian J Med Microbiol; 2012; 30(2):175-81. PubMed ID: 22664433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new high-level gentamicin resistance gene, aph(2'')-Id, in Enterococcus spp.
    Tsai SF; Zervos MJ; Clewell DB; Donabedian SM; Sahm DF; Chow JW
    Antimicrob Agents Chemother; 1998 May; 42(5):1229-32. PubMed ID: 9593155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the high-level aminoglycoside resistance gene aph(2")-Ib in Enterococcus faecium.
    Kao SJ; You I; Clewell DB; Donabedian SM; Zervos MJ; Petrin J; Shaw KJ; Chow JW
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2876-9. PubMed ID: 10991878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity among high-level aminoglycoside-resistant enterococci.
    Papaparaskevas J; Vatopoulos A; Tassios PT; Avlami A; Legakis NJ; Kalapothaki V
    J Antimicrob Chemother; 2000 Mar; 45(3):277-83. PubMed ID: 10702545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.
    Tripodi MF; Utili R; Rambaldi A; Locatelli A; Rosario P; Florio A; Ruggiero G
    J Antimicrob Chemother; 1996 Apr; 37(4):727-36. PubMed ID: 8722538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.